Humana Deferred Revenue decreased by 24.4% to $269.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.5%, from $265.00M to $269.00M. Over 4 years (FY 2021 to FY 2025), Deferred Revenue shows an upward trend with a 8.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests strong sales of subscription-based services or bundled offerings, providing a predictable pipeline for future revenue recognition.
Represents cash payments received from customers in advance of the company fulfilling its performance obligations, speci...
High-growth software and services companies typically maintain larger deferred revenue balances relative to pure hardware manufacturers.
deferred_revenue_current| Q4 '21 | Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $254.00M | $286.00M | $7.22B | $7.38B | $266.00M | $301.00M | $313.00M | $195.00M | $260.00M | $265.00M | $274.00M | $265.00M | $356.00M | $269.00M |
| QoQ Change | — | +12.6% | >999% | +2.2% | -96.4% | +13.2% | +4.0% | -37.7% | +33.3% | +1.9% | +3.4% | -3.3% | +34.3% | -24.4% |
| YoY Change | — | +12.6% | — | — | -7.0% | -95.8% | -95.8% | — | -2.3% | -12.0% | -12.5% | +35.9% | +36.9% | +1.5% |